Health and Fitness Health and Fitness
Thu, October 28, 2010
[ Thu, Oct 28th 2010 ] - Market Wire
Sycamore Entertainment Group Aggressively Pursuing Objectives
[ Thu, Oct 28th 2010 ] - Market Wire
Targacept to Report Third Quarter 2010 Financial Results on November 4, 2010
[ Thu, Oct 28th 2010 ] - Market Wire
Health Net Expands Mobile Capabilities
[ Thu, Oct 28th 2010 ] - Market Wire
InSite Vision to Report Third Quarter Financial Results on November 4, 2010
[ Thu, Oct 28th 2010 ] - Market Wire
Celgene comunica risultati finanziari e operativi record per il terzo trimestre del 2010
[ Thu, Oct 28th 2010 ] - Market Wire
Celgene Reports Record Third Quarter 2010 Operating and Financial Results
[ Thu, Oct 28th 2010 ] - Market Wire
ArthroCare Receives FDA Clearance for Spartan PEEK Suture Implant
[ Thu, Oct 28th 2010 ] - Market Wire
POZEN Reports Third Quarter 2010 Results
[ Thu, Oct 28th 2010 ] - Market Wire
Emeritus Corporation to Host Third Quarter 2010 Earnings Conference Call and Webcast
[ Thu, Oct 28th 2010 ] - Market Wire
Natus Medical Announces 2010 Third Quarter Financial Results
[ Thu, Oct 28th 2010 ] - Market Wire
ACADIA Pharmaceuticals Enters Agreement with Biov .. and Regain North American Rights to Pimavanserin
[ Thu, Oct 28th 2010 ] - Market Wire
Pro-Pharmaceuticals Ships First Commercial Order for DAVANAT®
[ Thu, Oct 28th 2010 ] - Market Wire
Curis Reports Third Quarter 2010 Financial Results
[ Thu, Oct 28th 2010 ] - Market Wire
BioCryst Reports Third Quarter 2010 Financial Results and Provides Corporate Update
[ Thu, Oct 28th 2010 ] - Market Wire
AngioDynamics Announces Election of Kevin J. Gould to Board of Directors
Wed, October 27, 2010
[ Wed, Oct 27th 2010 ] - Market Wire
Sanofi-aventis video Q&A: CFO J©r'me Contamine Comments on Results for Q3 2010
[ Wed, Oct 27th 2010 ] - Market Wire
Exact Sciencesa? Abstract Published in AACR Abstr .. dation Study Data Will Be Announced at 1:00 PM ED
[ Wed, Oct 27th 2010 ] - Market Wire
NeuroMetrix, Inc. Announces Date for 2010 Third Quarter Financial Results Conference Call
[ Wed, Oct 27th 2010 ] - Market Wire
Crown Oil and Gas Announces Appointment of Director
[ Wed, Oct 27th 2010 ] - Market Wire
Finkelstein Thompson LLP Announces Investigation of Clarient, Inc.
[ Wed, Oct 27th 2010 ] - Market Wire
NUVO RESEARCH ANNOUNCES 2010 THIRD QUARTER FINANCIAL RESULTS
[ Wed, Oct 27th 2010 ] - Market Wire
NPS Pharmaceuticals to Report Third Quarter 2010 Financial Results
[ Wed, Oct 27th 2010 ] - Market Wire
Somaxon Pharmaceuticals to Report Third Quarter 2 .. nd Conduct Conference Call on Tuesday, November 9
[ Wed, Oct 27th 2010 ] - Market Wire
Human Genome Sciences Announces Third Quarter 2010 Financial Results and Key Developments
[ Wed, Oct 27th 2010 ] - Market Wire
Dyax Corp. Announces Third Quarter 2010 Financial Results
[ Wed, Oct 27th 2010 ] - Market Wire
China Kanghui Holdings Announces Participation in Upcoming Investor Conferences
[ Wed, Oct 27th 2010 ] - Market Wire
Alnylam to Webcast Conference Call Discussing Third Quarter 2010 Financial Results
[ Wed, Oct 27th 2010 ] - Market Wire
Chemed Corporation to Present at the Oppenheimer 21st Annual Healthcare Conference
[ Wed, Oct 27th 2010 ] - Market Wire
Northstar Healthcare Announces Senior Management Changes
[ Wed, Oct 27th 2010 ] - Market Wire
IMRIS TO HOLD THIRD QUARTER 2010 RESULTS CONFERENCE CALL

IMRIS TO HOLD THIRD QUARTER 2010 RESULTS CONFERENCE CALL


Published on 2010-10-27 09:16:05 - Market Wire
  Print publication without navigation


WINNIPEG, Oct. 27 /CNW/ - IMRIS Inc. (TSX: IM)

Third Quarter 2010 Earnings Release November 4, 2010
Conference Call and Webcast November 4, 2010 4:30 pm ET
Hosted by

 David Graves, Chairman and Chief Executive
Officer;
Kelly McNeill, Executive Vice President,
Finance and Chief Financial Officer
Participant Numbers 416-644-3423 or 1-877-974-0449
Conference Call ID Number 4381039

A question and answer session for analysts and institutional investors will follow management's presentation. A taped rebroadcast will be available to listeners until 12 a.m. on November 11, 2010. To access the rebroadcast, please dial 416-640-1917 or 1-877-289-8525 and enter the passcode 4381039#.

About IMRIS

IMRIS (TSX: IM) is a global leader in providing image guided therapy solutions. These solutions feature fully integrated surgical and interventional suites that incorporate magnetic resonance, fluoroscopy and computed tomography to deliver on demand imaging during procedures. The Company's systems serve the neurosurgical, cardiovascular and neurovascular markets and have been selected by leading medical institutions around the world.

Contributing Sources